Members in the News

Dr. Brian Kim on the left, and Dr. David Artis on the right at their visit in February to Allen Institute in Seattle, WA. Photo from Dr Kim’s Twitter/X account.

Some dermatological disorders such as atopic dermatitis, alopecia areater, and vitiligo have few treatments available due to the lack of effective medications currently on the market. However, this might change soon with the formation of a new biotech entity called Alys Pharmaceuticals, Inc. that launched on 12th of February. It started with a substantial 100-million-dollar investment from Medicxi, the European healthcare investment fund, with the goal of transforming the treatment paradigm for several dermatology indications of significant prevalence and major unmet need. Alys, based in Boston and Geneva, is the combination of the assets and platforms of Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics, and has a world class leadership team that brings together experts across dermatology and advanced scientific fields. [READ MORE]

Congratulations ICIS member and former Council Member, Thirumala-Devi Kanneganti, PhD, for being awarded the 2024 AAI-Thermo Fisher Meritorious Career Award for her research identifying fundamental mechanisms and establishing new scientific paradigms connecting innate immunity, cell death, and disease. [READ MORE]

Hudson Institute’s world leading inflammation programs enter a new era with the appointment of Professor Seth Masters to head the Centre for Innate Immunity and Infectious Diseases (CiiiD).

An expert in genetic disorders that trigger inflammatory diseases, Prof Masters has spent the past 12 years as Head of the Inflammasomes and Autoinflammatory Disease Laboratory at the Walter and Eliza Hall Institute (WEHI). [READ MORE]

Inviting all ICIS Members to share their promotions, publications, mini-bios, meeting announcements, industry news, career opportunities, or other news of interest to the cytokine & interferon research community. Also, if you have a few minutes to provide a Member Highlights interview, please contact Joan Oefner [email protected] for inclusion in a future bimonthly issue of Signals+. Deadlines are the 1st and the 15th of each month. To find out more about industry ads, please click here ADVERTISE. [READ MORE]